Literature DB >> 35068192

Muscle miR-16 deletion results in impaired insulin sensitivity and contractile function in a sex-dependent manner.

Seongkyun Lim1, J William Deaver1, Megan E Rosa-Caldwell1, David E Lee1, Francielly Morena da Silva1, Ana Regina Cabrera1, Eleanor R Schrems2, Landen W Saling2, Tyrone A Washington2, James D Fluckey3, Nicholas P Greene1.   

Abstract

microRNAs (miRs) are linked to various human diseases including type 2 diabetes mellitus (T2DM) and emerging evidence suggests that miRs may serve as potential therapeutic targets. Lower miR-16 content is consistent across different models of T2DM; however, the role of miR-16 in muscle metabolic health is still elusive. Therefore, the purpose of this study was to investigate how deletion of miR-16 in mice affects skeletal muscle metabolic health and contractile function in both sexes. This study was conducted using both 1) in vitro and 2) in vivo experiments. In in vitro experiments, we used C2C12 myoblasts to test if inhibition or overexpression of miR-16 affected insulin-mediated glucose handling. In in vivo experiments, we generated muscle-specific miR-16 knockout (KO) mice fed a high-fat diet (HFD) to assess how miR-16 content impacts metabolic and contractile properties including glucose tolerance, insulin sensitivity, muscle contractile function, protein anabolism, and mitochondrial network health. In in vitro experiments, although inhibition of miR-16 induced impaired insulin signaling (P = 0.002) and glucose uptake (P = 0.014), overexpression of miR-16 did not attenuate lipid overload-induced insulin resistance using the diacylglycerol analog 1-oleoyl-2-acetyl-sn-glycerol. In in vivo experiments, miR-16 deletion induced both impaired muscle contractility (P = 0.031-0.033), and mitochondrial network health (P = 0.008-0.018) in both sexes. However, although males specifically exhibited impaired insulin sensitivity following miR-16 deletion (P = 0.030), female KO mice showed pronounced glucose intolerance (P = 0.046), corresponding with lower muscle weights (P = 0.015), and protein hyperanabolism (P = 0.023). Our findings suggest distinct sex differences in muscle adaptation in response to miR-16 deletion and miR-16 may serve as a key regulator for metabolic dysregulation in T2DM.NEW & NOTEWORTHY We set to investigate the role of miR-16 in skeletal muscle during diet-induced insulin resistance. Our data provide novel evidence that the lack of miR-16 induced multiple aberrations in insulin sensitivity, muscle contractility, mitochondrial network health, and protein turnover in a sex-dependent manner. Interestingly, miR-16 deletion leads to insulin resistance in males and exacerbated glucose intolerance in females, suggesting different mechanisms of metabolic dysregulation with a lack of miR-16 between sexes.

Entities:  

Keywords:  insulin resistance; microRNA; mitochondrial quality; protein turnover; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2022        PMID: 35068192      PMCID: PMC8897019          DOI: 10.1152/ajpendo.00333.2021

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  51 in total

1.  microRNA-16 Is Downregulated During Insulin Resistance and Controls Skeletal Muscle Protein Accretion.

Authors:  David E Lee; Jacob L Brown; Megan E Rosa; Lemuel A Brown; Richard A Perry; Michael P Wiggs; Mats I Nilsson; Stephen F Crouse; James D Fluckey; Tyrone A Washington; Nicholas P Greene
Journal:  J Cell Biochem       Date:  2016-01-15       Impact factor: 4.429

2.  Progressive resistance voluntary wheel running in the mdx mouse.

Authors:  Jarrod A Call; James N McKeehen; Susan A Novotny; Dawn A Lowe
Journal:  Muscle Nerve       Date:  2010-12       Impact factor: 3.217

3.  Insulin resistance syndrome blunts the mitochondrial anabolic response following resistance exercise.

Authors:  Mats I Nilsson; Nicholas P Greene; Justin P Dobson; Michael P Wiggs; Heath G Gasier; Brandon R Macias; Kevin L Shimkus; James D Fluckey
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-06       Impact factor: 4.310

4.  AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise.

Authors:  N Musi; N Fujii; M F Hirshman; I Ekberg; S Fröberg; O Ljungqvist; A Thorell; L J Goodyear
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

5.  Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg?

Authors:  Avan Aihie Sayer; Elaine M Dennison; Holly E Syddall; Helen J Gilbody; David I W Phillips; Cyrus Cooper
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

6.  Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.

Authors:  Jing Xu; Rongshan Li; Biruh Workeneh; Yanlan Dong; Xiaonan Wang; Zhaoyong Hu
Journal:  Kidney Int       Date:  2012-08       Impact factor: 10.612

7.  Mitochondrial quality control, promoted by PGC-1α, is dysregulated by Western diet-induced obesity and partially restored by moderate physical activity in mice.

Authors:  Nicholas P Greene; David E Lee; Jacob L Brown; Megan E Rosa; Lemuel A Brown; Richard A Perry; Jordyn N Henry; Tyrone A Washington
Journal:  Physiol Rep       Date:  2015-07

8.  Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.

Authors:  Jacob L Brown; Megan E Rosa-Caldwell; David E Lee; Thomas A Blackwell; Lemuel A Brown; Richard A Perry; Wesley S Haynie; Justin P Hardee; James A Carson; Michael P Wiggs; Tyrone A Washington; Nicholas P Greene
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-08-28       Impact factor: 12.910

9.  miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo.

Authors:  Samarjit Das; Djahida Bedja; Nathaniel Campbell; Brittany Dunkerly; Venugopal Chenna; Anirban Maitra; Charles Steenbergen
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

View more
  1 in total

Review 1.  Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease.

Authors:  Chengshun Li; Dongxu Wang; Ziping Jiang; Yongjian Gao; Liqun Sun; Rong Li; Minqi Chen; Chao Lin; Dianfeng Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.